1,2-distearoyllecithin has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krishna, R; Mayer, LD; St Onge, G; Webb, MS | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and Carcinoma, Lewis Lung
Article | Year |
---|---|
Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Lewis Lung; Cholesterol; Drug Carriers; Female; Injections, Intravenous; Liposomes; Mice; Phosphatidylcholines; Sphingomyelins; Tissue Distribution; Vincristine | 2001 |